Every June 21st marks World Amyotrophic Lateral Sclerosis (ALS) Day, a date dedicated to raising awareness about this neurodegenerative disease, driving scientific research, and promoting timely diagnosis. Although it is a fairly uncommon condition, its impact on patients’ mobility and quality of life makes early detection and access to quality medical care extremely vital.
The Progressive Loss of Movement
Amyotrophic Lateral Sclerosis is a neurodegenerative disease that affects motor neurons, which are responsible for transmitting the signals that enable voluntary movements such as walking, talking, moving limbs, or breathing. According to information published by neurologist Vicente Gajate García on the Clínica Universidad de Navarra website, ALS progressively deteriorates these functions due to the damage suffered by the neurons in charge of movement.
Likewise, specialists from the National Institute of Neurological Disorders and Stroke (NINDS) in the United States explain on their official site that the gradual loss of these cells causes muscle weakness and a progressive decrease in motor capacity. As the disease advances, muscles stop responding adequately to the signals sent by the brain.
However, one of the unique features of ALS is that, in many cases, intellectual capabilities are not negatively affected or limited by this condition. This means that patients are usually fully aware of the physical changes they experience.
Signs That Can Alert to the Disease
Symptoms of ALS can vary from person to person and, at times, can be confused with other neurological conditions. According to information published on the NINDS web portal, some of the most frequent manifestations include weakness in the arms or legs, difficulty walking, trouble holding objects, speech alterations, and difficulty swallowing food.
Because these signs typically appear gradually, many people may overlook the initial indications of the illness. Consequently, diagnosis represents one of the main challenges for specialists.
In a medical review published on the scientific platform NCBI Bookshelf, researchers point out that there is no single test capable of confirming ALS. Therefore, doctors must rely on neurological evaluations, complementary studies, and ruling out other pathologies with similar symptoms. This is why visiting a doctor promptly when continuous signs appear can contribute to an earlier detection, allowing for timely treatment.
A Reality in Venezuela That Also Requires Attention
The Venezuelan reality is no exception to this disease. In statements offered in February of this year on the Circuito Éxitos of Unión Radio, neurologist Adler Puerta Antúnez explained that between 1,000 and 2,500 people with Amyotrophic Lateral Sclerosis could be living in the country. Furthermore, he noted that the disease usually has a complex progression, as patient survival typically ranges between three and five years after diagnosis.
Beyond commemorating a specific date, World ALS Day represents an opportunity for Next Step to be part of the support needed by patients living with this disease, generating awareness by spreading information about its health implications. In this way, the company reaffirms its commitment to contributing to the improvement of patients’ quality of life and offering quality medical solutions in the country.
References:
- Clínica Universidad de Navarra. (n.d.). Esclerosis lateral amiotrófica (ELA). Author: Dr. Vicente Gajate García, Department of Neurology. https://www.cun.es/en/diseases-treatments/diseases/lateral-amyotrophic-sclerosis
- Mundo UR. (2026, February 26). Especialista estima que hasta 2.500 venezolanos padecen esclerosis lateral amiotrófica. https://mundour.com/2026/02/26/especialista-estima-que-hasta-2-500-venezolanos-padecen-esclerosis-lateral-amiotrofica/?utm_source=chatgpt.com
- National Center for Biotechnology Information. (2024). Amyotrophic lateral sclerosis. In StatPearls. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK556151/
- National Institute of Neurological Disorders and Stroke. (n.d.). Amyotrophic lateral sclerosis (ALS). National Institutes of Health. https://www.ninds.nih.gov/health-information/disorders/amyotrophic-lateral-sclerosis-als